FDA Inspection 1100374 — Gulf Coast Regional Blood Center at Westchase
The FDA completed an inspection of Gulf Coast Regional Blood Center at Westchase on June 14, 2019 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 14, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Houston, TX (United States)